HRES928119th Congress
Affirming support for most-favored-Nation drug pricing for United States patients.
Sponsored By: Representative Dingell, Debbie [D-MI-6]
Introduced
Summary
This resolution would endorse aligning U.S. drug prices with those in other developed countries. It also supports expanding Medicare drug price negotiation and promoting price competition to lower costs.
Show full summary
- Families and patients: Would aim to reduce out-of-pocket costs and cut cost-related nonadherence. Polling cited 21% did not fill a prescription and 1 in 7 cut or skipped doses because of cost.
- Medicare beneficiaries: Would back expanding Medicare drug price negotiation to seek lower prices for drugs covered by Medicare.
- Drug market: Would support policies that tie U.S. prices to those paid abroad and encourage competition among manufacturers.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Dingell, Debbie [D-MI-6]
MI • D
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov